Impaired Allogeneic Activation and T-helper 1 Differentiation of Human Cord Blood Naive CD4 T Cells  by Chen, Li et al.
I
D
C
I
i
n
a
n
a
l
t
[
s
L
Biology of Blood and Marrow Transplantation 12:160-171 (2006)
 2006 American Society for Blood and Marrow Transplantation
1083-8791/06/1202-0005$32.00/0
doi:10.1016/j.bbmt.2005.10.027
1mpaired Allogeneic Activation and T-helper 1
ifferentiation of Human Cord Blood Naive
D4 T Cells
Li Chen, Aileen C. Cohen, David B. Lewis
Department of Pediatrics and the Immunology Program, Stanford University School of Medicine,
Stanford, California
Correspondence and reprint requests: D. B. Lewis, MD, Division of Immunology and Transplantation Biology,
Department of Pediatrics, Stanford University School of Medicine, CCSR Bldg, Room 2115b, 269 Campus Dr,
Stanford, CA 94305 (e-mail: dblewis@stanford.edu).
Received June 25, 2005; accepted October 22, 2005
ABSTRACT
CD4 T cells, particularly those of the T-helper 1 (Th1) subset, are important effectors in alloimmune diseases,
such as graft-versus-host disease, and in controlling infections with intracellular pathogens. Thus, it is
plausible that impaired neonatal CD4 T-cell immunity might contribute to the low incidence of acute
graft-versus-host disease after allogeneic transplantation of hematopoietic stem cells using cord blood (CB)
compared with adult sources of hematopoietic stem cells. In support of this hypothesis, we found that CB naive
CD4 T cells had reduced activation and impaired early Th1 differentiation compared with adult peripheral
blood naive CD4 T cells after stimulation by allogeneic dendritic cells derived from adult monocytes. Early
Th1 polarization was dependent on interleukin-12 and CD154, and CB CD4 T cell/dendritic cell co-cultures
had impaired expression of both proteins. CB naive CD4 T cells had low basal levels of signal transduction and
activation of transcription 4 messenger RNA and protein, and, after alloantigen stimulation, reduced inter-
leukin-12-induced signal transduction and activation of transcription 4 tyrosine phosphorylation, compared
with adult peripheral blood naive T cells. Lastly, FoxP3 protein expression, a marker for regulatory CD25high
CD4 T cells, was lower for naive CD4 T cells of CB compared with those of adult peripheral blood, which
argued against increased T-regulatory activity as a mechanism for the decreased Th1 differentiation of CB
CD4 T cells. Together, these intrinsic limitations in T-cell activation and Th1 differentiation may impair the
ability of T cells in CB and the neonate to respond to allogeneic or infectious challenges.
© 2006 American Society for Blood and Marrow Transplantation
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Acute graft-versus-host disease (GVHD), in which
mmunocompetent transplanted donor T cells recog-
ize alloantigens presented by host cells [1,2], remains
major barrier to successful transplantation of alloge-
eic hematopoietic stem cells. After their infusion,
llogeneic donor T cells predominantly migrate to
ymphoid tissues where they become activated by in-
eracting with host or donor antigen-presenting cells
3], particularly the dendritic cell (DC) [4]. Recent
tudies suggest that CD4 antigenically naive rathersi Chen and Aileen Cleary Cohen contributed equally to this report.
60han memory T cells are mainly activated in the re-
ipient and are critical in initiating acute GVHD in
ivo [5-7]. Activated CD4 T cells then travel to non-
ymphoid tissues, such as the skin, gastrointestinal
ract, and liver, followed by CD8 T cells, where they
ause tissue damage [7] as effector CD4 and CD8 T
ells producing proinﬂammatory cytokines, such as
nterferon (IFN)- and tumor necrosis factor-, and
ytotoxins [8]. The importance of effector CD4 T
ells of the T-helper 1 (Th1) type, which produce
FN- but not T-helper 2 cytokines, in the immuno-
athogenesis of acute GVHD, especially for intestinal
athology [9], is supported by a number of animal
tudies [1].
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Impaired Neonatal CD4 T-Cell Allogeneic Activation
BAllogeneic hematopoietic stem cell transplanta-
ion using umbilical vein cord blood (CB) is associated
ith a decreased incidence and severity of acute
VHD compared with transplantation using adult
eripheral blood (APB) or bone marrow cells [10,11].
ecause CB contains a substantially higher concentra-
ion of naive T cells than either APB [12] or bone
arrow [13], these ﬁndings suggest that transplanted
B naive T cells have a reduced capacity to mediate
lloimmune responses in vivo. However, the mecha-
isms that are responsible for decreased GVHD after
llogeneic CB transplantation remain unclear.
Th1 effector cells are important for the control of
ntracellular microbes, particularly bacteria [14] and con-
ributing to the immunopathology of acute GVHD [1].
he activation and differentiation of naive CD4 T cells
nto Th1 effectors is initiated by engagement of -
-cell receptor (TCR) with antigenic peptide/major
istocompatibility complex (MHC) class II complexes
15]. DCs express high levels of MHC class II and
ostimulatory ligands, such as CD80 and CD86, and
re essential for activating naive CD4 T cells in re-
ponse to foreign antigens [16] and MHC alloantigens
n vivo [4]. DCs promote Th1 differentiation by se-
reting cytokines, such as interleukin (IL)-12, espe-
ially after engagement of their CD40 molecule by
D154 (CD40-ligand) on activated naive CD4 T cells
17]. Activated naive CD4 T cells also secrete IL-2
nd acquire high-afﬁnity receptors for IL-2 and IL-
2, which results in IL-2- and IL-12-dependent T-cell
roliferation [15,17] and facilitation of IFN- gene
ranscription [18].
The biologic effects of IL-12 are mainly depen-
ent on tyrosine phosphorylation of signal transducer
nd activator of transcription 4 (STAT4) [19] that
ccurs after IL-12 receptor engagement by its ligand.
ey STAT4-dependent events include increased CD4
-cell expression of IFN- [20], which, in turn, may
nhance CD4T-cell expression of T-bet, a transcription
actor that strongly favors Th1 and inhibits T-helper 2
evelopment [21]. IFN- produced early after naive
D4 T-cell activation may also favor Th1 differenti-
tion by helping to maintain functional IL-12 recep-
ors on the T-cell surface [20].
Regulatory CD4 T cells (Tregs) comprise a well-
haracterized population of cells that express high
evels of CD25 and play an important role in the
egative control of inﬂammation and in the mainte-
ance of tolerance to self [22,23]. Both human and
urine Tregs express high levels of the forkhead fam-
ly of transcription factors member FoxP3, whose ex-
ression is essential for programming Treg cell develop-
ent and function [24,25]. CB from term pregnancies
as been shown to have equivalent numbers of CD4 T
ells that are CD25high as APB [26]. These CD25highB T cells are able to suppress antigen-speciﬁc T-cell c
B&MTesponses in vitro [27,28], although to a lesser extent
han CD25high CD4 T cells of APB [29].
The possibility that decreased acute GVHD seen
n CB transplantations might be caused by impaired
h1 differentiation of CB CD4 T cells is currently
ot resolved. There is evidence that CD154 induction
ay be reduced on CB-derived T cells versus those
erived from adult blood sources [30-33]. However,
thers have demonstrated equivalent expression of
D154 after stimulation [34-36]. Although some
tudies show equivalent levels of IFN- by CB and
PB T cells after stimulation [34,35], others have
hown impaired IFN- production [37,38], depending
n the conditions used for stimulation [39]. Impor-
antly, none of the above studies analyze the early
vents of Th1 differentiation using puriﬁed CD4 naive
cells and allogeneic stimulation with mature DCs, the
nteraction thought to initiate acute GVHD [1].
We show here that naive CD4 T cells of CB
ompared with those of APB have impaired early
ctivation, IFN- expression, and IL-12 responsive-
ess after allogeneic stimulation with DCs, and an
mpaired ability to induce IL-12 production by DCs.
hus, multiple intrinsic limitations in CB CD4 T-cell
ctivation, which also limit DC function, impair the
ifferentiation of this CD4 T-cell population into
ffector Th1 cells, and these limitations account, in
art, for the decreased risk of acute GVHD after CB
ransplantation. We further found that FoxP3 expres-
ion, which is strongly associated with Treg cell func-
ion, is decreased in CB naive CD4 T cells that are
D25high, suggesting that these limitations in Th1
ifferentiation are an intrinsic property of naive CB
D4 T cells rather than a result of an increase in the
roportion of naive cells that are regulatory T cells.
ATERIALS AND METHODS
D4 T-Cell Purification
Naive (CD45RAhighCD45R0low) CD4 T cells were
uriﬁed by negative selection from APB or CB mono-
uclear cells of full-term neonates prepared by Ficoll-
ypaque density gradient centrifugation of anticoagu-
ated blood. The mononuclear cells were incubated
ith RosetteSep Cocktail for CD4 T cells (Stemcell
echnologies, Vancouver, British Columbia, Canada),
ollowed by incubation with paramagnetic beads
oated with monoclonal antibodies (mAbs) against
on-T-cell markers, CD8-, and CD45R0 (Miltenyi,
uburn, Calif), and application to a magnetic-acti-
ated cell sorter. Final purity as assessed by ﬂow cy-
ometry was routinely more than 95%.
onocyte-Derived DCs
Monocytes were isolated from APB mononuclear
ells using CD14 mAb-coated paramagnetic beads
161
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1Miltenyi) and positive selection using the magnetic-
ctivated cell sorter. Monocytes were cultured (5.0 
05/mL) for 7 days in complete RPMI-1640 medium
40] with 10% heat-inactivated human AB serum plus
ecombinant human granulocyte macrophage-colony-
timulating factor (25 ng/mL) (Immunex Corp, Seattle,
ash) and recombinant IL-4 (20 ng/mL) (Peprotech,
ocky Hill, NJ). Recombinant human tumor necrosis
actor- (10 ng/mL) (Biosource, Camarillo, Calif) was
dded after day 7, and mature monocyte-derived DCs
ere harvested on day 9 and cryopreserved in 7% (vol/
ol) dimethylsulfoxide (Sigma Chemical, St Louis,
o) in heat-inactivated human AB serum. Unless oth-
rwise indicated, equal numbers of DCs from 3 unre-
ated donors were pooled together for allogeneic stim-
lation.
llogeneic Stimulation of Naive CD4 T Cells
Equal numbers (2 105-1 106 at 1.5 106/mL)
f adult or CB-derived naive CD4 T cells were stim-
lated with allogeneic DCs (1.5  105/mL) in 200 L
f complete RPMI-1640 medium in 96-well ﬂat-bot-
om plates for 24 to 72 hours. For intracellular cyto-
ine staining, brefeldin A (10 g/mL) (Sigma Chem-
cal) was added for the last 4 hours of a 48-hour
timulation.
rimary Antibodies
Mouse-antihuman biotinylated CD154 (clone 24-
1) (Ancell, Bayport, Minn); phycoerythrin (PE)-Cy5-
D4 (clone S3.5) (Caltag, Burlingame, Calif); PE-
D69 (clone CH4, Caltag); ﬂuorescein isothiocyanate
FITC)-CD45RA (clone L48) (BD Biosciences, Moun-
ain View, Calif); allophycocyanin-CD45RO (clone
CHL1) (BD Biosciences); PE-CD25 (clone CD25-
G10) (Caltag); and FITC-IFN- (clone 25723.11)
BD Biosciences) mAbs were used for ﬂow cytometric
nalysis and cell isolation. Appropriate biotinylated or
uorochrome-conjugated mouse isotype control
Abs (Caltag) were used as negative controls. Uncon-
ugated mouse antihuman CD154 (clone, 5C8, IgG2a)
nd IL-12 (clone 24910.1, IgG1) (R and D Systems,
inneapolis, Minn) mAbs or equivalent concentra-
ions of sodium azide-free murine IgG1 and IgG2a
sotype controls (Sigma Chemical) were used for neu-
ralization experiments. Rabbit antihuman STAT4
nd phosphotyrosine (pY)-STAT4 antisera, and pre-
mmune sera were purchased from Zymed, South San
rancisco, Calif. FoxP3 antibody and isotype control
ere purchased from eBioscience, San Diego, Calif.
ytokine Assays
Cell culture supernatants were analyzed for cyto-
ine content using enzyme-linked immunoassay kits
or IFN-, IL-2, IL-4, IL-10 (OptEIA, BD Bio-
ciences), and IL-12 (Quantikine HS immunoassay 4
62it, R and D Systems). The lower limit of sensitivity
or each of the cytokine enzyme-linked immunosor-
ent assays were as follows: IFN-, 1.0 pg/mL; IL-2,
.0 pg/mL; IL-4, 2.0 pg/mL; IL-10, 2.0 pg/mL; and
L-12, 0.5 pg/mL.
ell Staining and Flow Cytometric Analysis
Staining for cell surface proteins and intracellular
ytokine staining, poststaining ﬁxation, and ﬂow cyto-
etric analysis were performed as previously described
40,41]. The number of cells analyzed per condition by
ow cytometry was no less than 10,000 naive CD4 T
ells, and was often between 20,000 to 50,000 events,
epending on the experiment. FoxP3 staining was
ccomplished using anti-FoxP3 antibodies directly
onjugated to FITC versus isotype controls (both
rom eBiosciences). These were used in the intracel-
ular staining assay following a protocol provided by
he manufacturer.
eal-Time Reverse-Transcriptase Polymerase
hain Reaction Analysis
Total RNA was isolated, converted to comple-
entary DNA, and polymerase chain reaction ampli-
ed in triplicate using an ABI Prism 5700 instrument
Applied Biosystems, Foster City, CA) and SYBR green
ye (Applied Biosystems, Foster City, CA) as previously
escribed [40]. Oligonucleotide primer pairs used for
mpliﬁcation were human STAT4 [nucleotide (nt)1387F
=-TGCCTCTATGGCCTGACCAT-3= and nt1438R
=-TCACCACAGGCAATGAGCTG-3=] and previ-
usly reported [40] 18S ribosomal RNA primers. The
ycle threshold (Ct) value, the calculated polymerase
hain reaction cycle at which products ﬁrst became
etectable, was determined using software (ABI). Ct
alues for 18S ribosomal RNA, which assessed the
ffectiveness of reverse transcription and polymerase
hain reaction ampliﬁcation, were used for normaliza-
ion of the STAT4 transcript Ct values. Levels of
TAT4 messenger RNA (mRNA) relative to those
ound in freshly isolated naive CB CD4 T cells were
alculated from Ct values using the formula 2Ct.
otal RNA from CD69hi CD4 T cells was isolated
fter 24 hours of stimulation with allogeneic DCs by
ncubating cultured cells with PE-conjugated CD69
Ab, and positively selecting CD69hi cells using
E-speciﬁc paramagnetic microbeads (Miltenyi)
nd a magnetic-activated cell sorter. The ﬁnal CD69hi
ell fraction contained less than 0.1% DCs based on
ight microscopic cellular morphology.
TAT4 Flow Cytometric Assays
Intracellular total STAT4 staining was performed
s previously described [42]. For pY-STAT4 staining,
aive CD4 T cells were allogeneically stimulated for
8 hours and then incubated with 20 ng/mL of re-
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Impaired Neonatal CD4 T-Cell Allogeneic Activation
Bombinant IL-12 (Genetics Institute, Boston, Mass)
or 20 minutes at 37°C. Cells were treated with ﬁxa-
ion reagent A (Fix and Perm, Caltag) for 2 to 3
inutes at room temperature, followed by the addi-
ion of an equal volume of ice-cold methanol for 10
inutes. Cells were washed, permeabilized with re-
gent B (Caltag), stained at room temperature with
rimary STAT4 antibodies or preimmune rabbit sera
or 30 minutes, followed by incubation with FITC-
onjugated goat antirabbit IgG (Caltag) for 20 minutes,
nd then immediately analyzed by ﬂow cytometry.
tatistics
Data are presented as mean  SEM. P values for
ifferences between means were calculated using the
-tailed, unpaired Student t test.
ESULTS
educed Naive CB CD4 T-Cell Expression of CD69
nd CD154 after Stimulation by Allogeneic DCs
To determine if CB and APB naive CD4 T cells
iffered in their ability to respond to optimal antigenic
igure 1. Reduced activation of CB naive CD4 T cells by allogene
cells after incubation with or without allogeneic DCs for 24 hour
D154 or CD69. DC1, DC2, and DC3 represent DC lines derived
ndicates pool of these 3 DC lines. Events shown are gated for CD4
ells. Results shown are representative of at least 6 independent experime
B&MTtimulation, these ells were co-cultured with mono-
yte-derived DCs from unrelated adult blood donors.
Cs were selected as allogeneic stimulators because of
heir physiologic relevance as antigen-presenting cells
or naive CD4 T-cell activation in vivo [16], including
n the context of GVHD [4], and their potency as acti-
ators, which enhanced our ability to analyze T-cell
esponses using ﬂow cytometry. Naive CD4 T cells
o-cultured individually with 3 different allogeneic
C lines were ﬁrst analyzed for their expression of
D69 and CD154, which are induced early after ac-
ivation [43,44]. Each DC line induced a substantial
roportion of APB naive CD4 T cells to express
D69 (Figure 1A). Pooling of the DC lines from 3
nrelated individuals consistently induced greater
mounts of CD69 than any of the individual lines,
onsistent with the pool providing a greater number
f MHC class II alloantigenic determinants. CB naive
D4 T cells under these conditions had a signiﬁcantly
ower percentage of CD69	 cells than APB naive cells
CB and APB CD4 T-cell percentages of 6.60  1.35
nd 13.08  2.68, respectively, n 
 6, P 
 .005). The
mount of CD69 per cell was similar based on mean
. CD69 (A) and CD154 (B) expression on APB and CB naive CD4
were analyzed by ﬂow cytometric analysis for CD4, CD45RA, and
unrelated healthy adult blood donors, respectively, and DC1	2	3
ymphocytes, with boxed numbers indicating percentage of positiveic DCs
s. Cells
from 3
5RA	 lnts.
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1uorescent index (MFI) measurements (CB and APB
D4 T-cell MFI of 237  19 and 282  18, respec-
ively, P
 .12). In contrast, CB naive CD4 T cells had
signiﬁcant reduction in both the percentage of
D154 positive cells (Figure 1B; CB and APB CD4
-cell values of 2.9  0.4 and 5.9  0.7, respectively,

 7, P 
 .001) and the level of CD154 per positive
ell (CB and APB CD4 T-cell MFI values of 134 18
nd 325  52, P 
 .002). In subsequent experiments,
pool of 3 DC lines was used to maximize the CD4
-cell response to alloantigens, and to limit any po-
ential impact of chance matching of MHC class II
igure 2. Reduced cytokine production by co-cultures of CB naive
ontent in cell culture supernatants by enzyme-linked immunosorbe
ars) after 48 hours of co-culture with allogeneic DCs. *P  .05 com
ccumulation in supernatants of ABP (solid line) or CB (dashed line)
epresentative of 3 independent experiments.lleles between stimulator and responder cells. a
64educed IFN-, IL-2, and IL-12 Production by
ultures of CB CD4 T Cells with Allogeneic DCs
The cytokine content of supernatants from co-
ultures of CB or APB naive CD4 T cells with allo-
eneic DCs was analyzed. As expected, IFN-, IL-2,
L-4, IL-10, and IL-12 were not detected in superna-
ants of naive CD4 T cells or DCs cultured alone
Figure 2A). Co-cultures of APB naive CD4 T cells
ith DCs produced substantially greater amounts of
FN-, IL-2, and IL-12 compared with those contain-
ng CB CD4 T cells (Figure 2A). Peak levels of IL-2
cells with allogeneic DCs. A, IFN-, IL-2, IL-4, IL-10, and IL-12
(ELISA) of naive CD4 T cells from APB (open bars) or CB (closed
with adult CD4 T-cell co-cultures. B, Kinetics of IFN- and IL-2
CD4 T-cell co-cultures with allogeneic DCs by ELISA. Results areCD4 T
nt assay
pared
naivend IFN- were achieved at 48 and 72 hours of incu-
b
c
l
c
C
i
o
I
v
[
T
w
e
m
C
D
F
C
o
a
o
o
c
w tive of
Impaired Neonatal CD4 T-Cell Allogeneic Activation
Bation, respectively, in APB or CB CD4 T-cell co-
ultures with DCs (Figure 2B). Substantially lower
evels of IFN- were also observed in CB CD4 T
ell/DC cultures compared with cultures of ABP naive
D4 T cell/DC cultures for at least 120 hours of
ncubation (Figure 2B). This suggests that the events
f T-cell activation required for de novo IL-2 and
FN- mRNA expression by CD4 T cells, e.g., acti-
igure 3. IFN- production by naive CD4 T cells after allogeneic
D4 T cells were incubated with allogeneic DCs for 48 hours in pr
r isotype-matched control mAbs. Intracellular IFN- accumulation
re CD45RAhigh lymphocytes, with boxed numbers indicating perce
f co-cultures of CD4 T cells and DCs. AB or CB naive CD4	 T
r absence of anti-CD154 antibody (5c8), or anti-IL-12 or their is
ulture, supernatants were harvested and measured for IFN- or IL
ith isotype control mAb incubation. Results shown are representaation of nuclear factor of activated T-cell proteins q
B&MT45], occurred in CB CD4 T cells without a major lag.
he delayed appearance of IFN- relative to IL-2 that
as observed was also consistent with most IFN-
xpression, but not IL-2 expression, requiring chro-
atin remodeling linked with cell division [18].
Reduced intracellular accumulation of IFN- by
B naive CD4 T cells after co-culture with allogeneic
Cs was also evident (Figure 3A), with both the fre-
mulation is dependent on IL-12 and CD154. A, APB or CB naive
or absence of 10 g/mL of neutralizing CD154 or IL-12 p70 mAb
B (top) or CB (bottom) naive CD4 T cells is shown. Events shown
nd MFI of IFN-	 cells. B, IFN- or IL-12 levels in supernatants
 105) were incubated with allogeneic DCs (3  104) in presence
ontrol antibodies IgG2a, or IgG1, at 10g/mL. After 48 hours of
ntent by enzyme-linked immunosorbent assay. *P  .05 compared
3 independent experiments.DC sti
esence
in AP
ntage a
cells (3
otype c
-12 couency of IFN-	 cells and the amount of IFN-
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1roduced per positive cell, based on MFI measure-
ents, being substantially lower compared with APB
aive CD4 T cells. No IFN- accumulation by DCs
ould be detected in these co-cultures (data not
hown), although DCs are a potential source of this
ytokine [46]. We were also unable to detect eithers
66L-2 or IL-12 expression by co-cultured cells using
ntracellular cytokine staining, most likely because of
he relatively low levels of these proteins per cell.
owever, CD4 T cells were likely the major source of
L-2 and DCs the major source of IL-12, based on
revious studies by others [15,17].
ultures of CB CD4 T Cells and Allogeneic DCs
roduce IL-10 but Not IL-4
The production of IL-4 by either APB or CB CD4
-cell co-cultures with DCs was low to undetectable
Figure 2A). Thus, there was no evidence for CB CD4
cells being prone to T-helper 2 polarization after
ptimal stimulation with mature DCs, although this
ight still apply to less optimal activation conditions
47]. APB and CB CD4 T-cell co-cultures with DCs
oth produced readily detectable and similar amounts of
L-10 (Figure 2A), which has multiple antagonistic ef-
ects on the generation of Th1 immunity [48]. As was
he case for IL-2 and IL-12, intracellular staining for
L-10 was not detectable so that the relative contri-
ution of DCs and CD4 T cells to IL-10 production
ould not be determined.
ole of Decreased CD154 and IL-12 in Limiting
B CD4 Th1 Polarization
Previous studies have shown that CD154 expres-
ion and IL-12 are critical for the in vivo accumulation
f human Th1 memory cells [40,49]. In co-cultures
f APB naive CD4 T cells with allogeneic DCs, we
ound that speciﬁc neutralization of either CD154 or
L-12 reduced the frequency of CD4 T cells that
xpressed IFN- intracellularly (Figure 3A) and the
evel of IFN- protein in cell culture supernatants
Figure 3B) and this occurred to a similar extent with
ither APB or CB-derived naive CD4 T cells. IL-12
evels were also speciﬁcally and markedly decreased in
ultures containing neutralizing CD154 mAb (Figure
igure 4. Reduced STAT4 expression and IL-12-induced tyrosine
hosphorylation of STAT4 by CB naive CD4 T cells. A, STAT4
RNA levels in CB and APB naive CD4 T cells immediately after
solation or in naive CD4 T cells expressing CD69 after 24 hours of
lloantigenic stimulation. Transcript level for freshly isolated CB
aive CD4 T cells was arbitrarily assigned value of 1.0 for compar-
son. Ct values were normalized using 18S ribosomal RNA as
nternal control. *P  .05 compared with corresponding CB CD4
-cell subset. B, Intracellular STAT4 protein in APB (top) or CB
aive (bottom) CD4 T cells, with number in left upper corner
ndicating percentage of cells staining positive by ﬂow cytometry. C,
low cytometric analysis of intracellular pY-STAT4 expression by
llogeneically primed CB and APB naive CD4 T cells after brief
reatment with IL-12. Events shown are for CD45RA	 CD4 T
ells, with numbers indicating percentage of positive cells. For all
anels, one of 3 independent experiments with similar results is
hown.
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BB), indicating that IL-12 production was dependent,
n part, on CD154 expression.
ecreased STAT4 Expression and Activation
n Naive CB CD4 T Cells
We next determined if decreased expression of
TAT4, which plays a critical role in Th1 differenti-
tion [20,21], might contribute to reduced CB CD4
-cell IFN- production after allogeneic stimulation.
reshly puriﬁed CB naive CD4 T cells had STAT4
ranscript levels that were approximately 20-fold
ower than those of APB naive CD4 T cells (Figure
A). These marked differences in STAT4 mRNA ex-
ression were also observed at the protein level (Fig-
re 4B). To determine if STAT4 expression was in-
reased by allogeneic priming, total RNA from CB or
PB naive CD4 T cells that were CD69	 after co-
ulture with allogeneic DCs was analyzed. Although
riming consistently increased STAT4 mRNA ex-
ression for both CD4 T-cell types relative to their
asal levels, primed CB CD4 T cells still had reduced
evels of STAT4 transcripts (Figure 4A) and protein
data not shown) compared with APB cells. These
ifferences in STAT4 expression were of functional sig-
iﬁcance, in that allogeneically primed CB naive CD4 T
ells had a substantially decreased expression of pY-
TAT4 after IL-12 treatment compared with similarly
ultured and IL-12-treated APB naive CD4T cells (Fig-
re 4C). No pY-STAT4 was detectable in cultured CD4
cells in the absence of IL-12 treatment.
educed FoxP3 Expression in CD25high CB Naive
D4 T Cells
CD25high CD4 T cells include a population of
igure 5. Decreased FoxP3 expression by naive CD4 T cells of the
f naive (CD45RAhigh) CD4 T cells from APB (top) and CB (botto
D25/low cells (low right quadrant) and percentage of CD25high
ndicated. B, Intracellular FoxP3 expression in freshly isolated CD2
istogram (isotype control) is compared with solid line (FoxP3). C
cells. Filled histogram (isotype control) is compared with solid lregs that are known to be important in preventing c
B&MTutoimmune disease, in mediating peripheral trans-
lantation tolerance, and in dampening the immune
esponse to endogenous bacterial ﬂora and pathogens
22,23]. Thus, it is plausible that these cells may also
imit the activation of and cytokine production by
aive CD4 T cells in acute GVHD. To determine
hether an increased proportion of Tregs among na-
ve CD4 T cells in CB might limit their ability to
ifferentiate into Th1 cells, we ﬁrst examined the
ercentage of naive CD4 T cells that expressed CD25
n CB versus APB. A slightly lower percentage of CB
aive CD4 T cells expressed high levels of CD25
ersus APB naive CD4 T cells (Figure 5A). Because
oxP3 expression has been strongly correlated to Treg
unction [24,25], we next examined FoxP3 protein level
n APB versus CB naive CD4 T cells. Although a sub-
tantial fraction of CD25high naive CD4 T cells in both
B and APB expressed FoxP3 protein, this percentage
or APB CD25high CD4 naive T cells was almost twice
hat of the analogous CD25high CD4 naive T-cell
opulation in CB (Figure 5B). Neither APB nor CB-
erived CD4 T cells that were CD25/low expressed
oxP3 protein (Figure 5C). Because FoxP3 expression
s thought to tightly correlate with Treg development
nd function, these data suggest that increased Treg
ctivity within the CB naive CD4 T-cell population
oes not play a role in limiting activation and differ-
ntiation into Th1 cells compared with APB naive
D4 T cells.
ISCUSSION
The transplantation of allogeneic CB is associated
ith a lower incidence and severity of acute GVHD
high subset from CB compared with APB. Flow cytometric analysis
shown. A, CD4 versus CD25 surface expression, with percentage
d MFI for CD25 of CD25high population (upper right quadrant)
ive CD4 T cells, with percentage of positive cells indicated. Filled
ellular FoxP3 expression in freshly isolated CD25/low naive CD4
xP3), and percentage of positive cells is indicated.CD25
m) are
cells an
5high na
, Intracompared with transplantation using allogeneic pe-
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1ipheral blood or bone marrow from adults as sources
f hematopoietic stem cells [10,11]. Recent studies
uggest that the naive rather than memory/effector
D4 T cells are an important determinant of acute
VHD [5-7] and, therefore, that naive T cells are
mportant precursors of effector cells producing Th1
ytokines and cytotoxins that are implicated in this
isease [1,2]. Because CB contains a substantially
igher concentration of naive CD4 and CD8 T cells
xpressing a diverse surface -TCR repertoire [50]
han either ABP [12] or bone marrow [13], these
ndings suggest that the functional capacity of naive T
ells in CB to mediate GVHD after transplantation
ay be limited compared with naive T cells from
dult sources. In this study, we used allogeneic DCs, a
ell type that is highly effective in naive T-cell acti-
ation [16] and that is likely to play a central role in
cute GVHD [4], to activate highly puriﬁed naive
D4 T cells from CB or APB in vitro. Our results
eveal multiple T-cell intrinsic mechanisms that are
ikely to limit the acquisition of Th1 effector function
n vivo by naive CD4 T cells in CB after their trans-
lantation into an allogeneic recipient.
The major difference between our study and pre-
ious observations that compare CD154 or cytokine
xpression using APB or CB T cells [34,35,37,38] is
he demonstration of impairment in early allostimu-
ation events using mature DC populations that are
o-cultured with puriﬁed naive CD4 T cells rather
han a mixture of naive and memory cells. A compar-
son of puriﬁed naive CD4 T cells from APB versus
B is important because memory T cells have a sub-
tantially lower activation threshold and mediate rapid
ffector responses compared with naive T cells [51].
e also focused on naive CD4 T cells, because this
ubset appears to be critical in the initiation of acute
VHD immunopathogenesis [5-7]. Another differ-
nce from earlier studies using allogeneic stimulation
ith DCs [34,35] is that we analyzed our cells and
ulture supernatants for activation-dependent pro-
eins and responsiveness to IL-12 at a shorter interval
fter stimulation (i.e., 24-120 hours) rather than
onger periods. In contrast to other studies [34,35], we
lso did not perform restimulation of alloantigen
rimed CD4 T cells with pharmacologic stimuli, such
s calcium ionophore and phorbol ester. Our focus
as to determine whether there were differences in
llogeneic activation and early Th1 differentiation be-
ween naive CD4 T cells from CB versus APB that
ight have clinical relevance to the early events in the
nitiation of acute GVHD.
Despite their diverse -TCR repertoire, CB na-
ve CD4 T cells had a signiﬁcantly lower percentage
f cells expressing CD69 than APB naive CD4 T cells
fter allogeneic DC stimulation. The level of CD69
er cell was similar for both naive CD4 T-cell types.
n contrast, both the frequency and the amount of d
68D154 per cell were signiﬁcantly reduced on CB
aive CD4 T cells compared with APB cells. These
esults obtained using a physiologically relevant anti-
en-presenting cell population for -T-cell stimula-
ion support previous observations in which engage-
ent of the -TCR/CD3 complex using mAbs and
acterial superantigens was used, and which also
howed that CB naive CD4 T cells had substantially
reater limitations in CD154 than in CD69 expression
ompared with APB CD4 T cells [33]. These differ-
nces in the capacity of CB CD4 T cells for the
xpression of CD69 versus CD154 are consistent with
n early bifurcation in the signal transduction path-
ays that lead to the induction of de novo transcrip-
ion of the CD69 and CD154 genes after T-cell acti-
ation: CD69 gene expression is mainly dependent on
horbol ester-inducible events [52], such as activation of
as and protein kinase C [53], while CD154 gene tran-
cription requires a combination of both calcium-depen-
ent and ras/protein kinase C-mediated signals [45].
Although the role of CD69 in T-cell activation or
ffector function remains poorly understood, CD154
xpression has previously been shown to play multiple
oles in naive CD4 T-cell activation that are mediated,
n large part, by engagement of CD40 on DCs [44].
hese include increasing DC expression of costimu-
atory molecules and the production of IL-12 p70
54]. A decrease in these CD154-dependent mechanisms
s also likely to account for the absence of antigen-
peciﬁc memory CD4 T cells secreting IFN- in human
eings with genetic deﬁciency of CD154 [49]. Using a
eutralizing antibody to CD154, we conﬁrmed that
he DC-derived IL-12 p70 production and early
FN- expression by APB naive CD4 T cells was
D154-dependent after allogeneic stimulation with
Cs. CD154 neutralization also reduced the relatively
ow levels of production of IL-12 by DCs and IFN-
y naive CD4 T cells in CB CD4 T-cell/DC co-
ultures, indicating a CD154-dependent pathway for
h1 differentiation also applied to CB CD4 T cells in
n allogeneic context. Studies by others have also
emonstrated the importance of CD154 [55] and IL-
2/STAT4 [9] in the pathogenesis of acute GVHD.
ogether, these results indicate that reduced CD154
xpression by CB naive CD4 T cells after allostimu-
ation and its impact on recipient DC cytokine pro-
uction plays an important role in limiting early Th1
ell differentiation of cells involved in acute GVHD.
We found that allogeneic priming of CB or APB
aive CD4 T cells resulted in increased STAT4
RNA and protein expression. To our knowledge,
his striking up-regulation of STAT4 protein expres-
ion by T-cell activation has not been described pre-
iously, and determining the signal transduction and
olecular mechanisms by which this is achieved will
e of interest. Our data conﬁrm a previous report of
ecreased STAT4 transcript levels in CB T cells by
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Bicroarray analysis [56]. We furthered these ﬁndings
y showing that CB naive CD4 T cells had signiﬁ-
antly lower basal levels of STAT4 protein than APB
aive CD4 T cells, and a relatively reduced level of
TAT4 protein by CB CD4 T cells persisted after
llogeneic priming. This reduced expression of
TAT4 may have contributed to the decreased fre-
uency of IL-12-induced pY-STAT4 in naive CB
D4 T cells compared with APB cells after allogeneic
riming. These results do not exclude the possibility
hat allogeneic priming was less effective in CB naive
D4 T cells in up-regulating IL-12 receptor surface
xpression, although our inability to ﬂow cytometri-
ally detect the two components of the IL-12 recep-
or, IL-12R1 or IL-122, on allogeneically primed
D4 T cells precluded testing this possibility.
Regardless of the relative contribution of receptor
ersus postreceptor limitations in IL-12 signaling, our
esults suggest that not only decreased IL-12 produc-
ion but also reduced STAT4-mediated events limit
he Th1 differentiation of naive CB CD4 T cells by
lloantigen. Because STAT4 appears to play an im-
ortant role in acute GVHD [9], both reduced IL-12
roduction and a diminished capacity to mediate
TAT4-dependent events may contribute to the re-
uced risk of acute GVHD after transplantation with
llogeneic CB.
IFN- appears to up-regulate expression of T-bet, a
aster transcription factor that promotes Th1 differen-
iation, although the precise mechanism by which T-bet
cts remains controversial. IFN- may also act directly
n activated naive CD4 T cells to maintain IL-12R2
xpression, and this effect is dependent on STAT1
20]. Therefore, it is plausible that reduced early
FN- secretion by naive CB CD4 T cells after allo-
eneic stimulation might act in an autocrine or para-
rine manner to reduce Th1 differentiation compared
ith ABP CD4 T cells.
IL-10 is an anti-inﬂammatory cytokine known to
ecrease tumor necrosis factor- and IFN- produc-
ion and aid in graft tolerance, possibly through the
roduction of regulatory T-cell populations [57]. In
ddition, IL-10 production by donor T cells has been
hown to reduce the severity of acute GVHD in ani-
al models [58]. Moreover, others have demonstrated
ncreased levels of IL-10 from CB naive CD4 T cells
hat have been stimulated with anti-CD3 mAb with or
ithout anti-CD28 mAb and IL-2 for 6 days [59] or
fter phorbol myristate acetate and ionomycin stimu-
ation after a 7-day co-culture with mature monocyte-
erived DCs [35]. These observations raised the pos-
ibility that regulatory T cells may be increased in the
B population based on this cytokine proﬁle. How-
ver, we found that co-cultures of DCs with naive
D4 T cells derived from either CB or APB produced
imilar low but detectable amounts of IL-10 after 48
ours of co-culture. It is possible that IL-10 produc- l
B&MTion differs based on the mode of stimulation (DCs
ersus anti-CD3 mAb versus phorbol ester/ionomy-
in), or that increased incubation time is necessary for
ptimum IL-10 expression, and that IL-10 may play a
ole in inhibiting later events in acute GVHD.
Regardless of the cellular source, the higher IL-
0:IFN- ratio for CB compared with the APB naive
D4 T-cell co-cultures with DCs, which is a result of
he reduced secretion of IFN- in the CB co-cultures,
ight limit IFN--dependent functions. For example,
L-10 may reduce IFN--mediated gene expression
y suppressing STAT1 tyrosine phosphorylation [60],
t is plausible that this high ratio might limit IFN--
ependent enhancement of Th1 differentiation, such
s augmented IL-12 receptor expression, which also
equires STAT1 [20].
We considered the possibility that decreased
riming of CB naive CD4 T cells toward Th1 re-
ponses might be a result of increased proportion of
egulatory T cells in this naive cell population com-
ared with that of ABP. Although our data support
rior observations that CB and APB have similar
umbers of naive CD4 T cells that are CD25high [26],
he observation that a smaller fraction of these express
oxP3 protein suggests that the naive CD4 T-cell
ompartment of CB has a lower concentration of bona
de Tregs than naive CD4 T cells of APB. Together,
hese results suggest that the decreased Th1 differen-
iation observed after allogeneic stimulation of naive
D4 T cells from CB is unlikely to be a result of
ncreased Treg activity in this cell population, but
ather defects that are intrinsic to naive CD4 T cells
hat are CD25/low.
The results of these studies are also of interest in
eﬁning limitations in CB CD4 T-cell immunity, par-
icularly by Th1 cells, in response to infection or
accination. For example, the human neonate and
nfant are highly vulnerable to severe or persistent
nfection with herpesviruses, such as herpes simplex
irus and cytomegalovirus, and these susceptibilities
re associated with decreased and delayed acquisition
f antigen-speciﬁc CD4 T-cell immunity, including
h1 function, compared with adults [41,61]. Because
ecent studies support the idea that -TCR engage-
ent by complexes of either peptide/allogeneic MHC
r foreign peptide/self-MHC are structurally similar
62], it is likely that these limitations of CD4 T-cell
ctivation by allogeneic stimulation also apply to ac-
ivation by foreign peptides bound to self-MHC mol-
cules, and contribute to the reduced CD4 T-cell
esponses of the neonate to intracellular infections,
uch as with herpesviruses [39].
In summary, our results reveal multiple mecha-
isms–including reduced expression of IFN-, IL-2,
L-12, CD154, and a reduced capacity for IL-12-
ependent STAT4 tyrosine phosphorylation–that
imit the activation of CB naive CD4 T cells and their
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1h1 polarization after allostimulation by mature DCs.
hese in vitro studies argue strongly for a functional
imitation in naive CB T-cell activation in vivo in
esponse to allogeneic stimuli as an important mech-
nism for the relatively low risk of acute GVHD after
ransplantation using allogeneic CB.
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